Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938674411> ?p ?o ?g. }
- W2938674411 endingPage "89" @default.
- W2938674411 startingPage "78" @default.
- W2938674411 abstract "Patients with advanced hepatocellular carcinoma (HCC) will almost always develop acquired tolerance after sorafenib therapy, and the molecular mechanism of sorafenib tolerance remains poorly characterized. Here, using our established sorafenib-resistant HCC cell and xenograft models, we identified a novel gene, KIAA1199, which was markedly elevated among the differentially expressed genes involved in sorafenib tolerance. Moreover, elevated expression of KIAA1199 was positively correlated with a high risk of recurrence and metastasis and advanced TNM stage in HCC patients. Functionally, loss- and gain-of-function studies showed that KIAA1199 promoted the migration, invasion, and metastasis of sorafenib-resistant HCC cells. Mechanistically, KIAA1199 is required for EGF-induced epithelial-mesenchymal transition (EMT) in sorafenib-resistant HCC cells by aiding in EGFR phosphorylation. In summary, our data uncover KIAA1199 as a novel sorafenib-tolerant promoting gene that plays an indispensable role in maintaining sorafenib-resistant HCC cell metastasis." @default.
- W2938674411 created "2019-04-25" @default.
- W2938674411 creator A5005549879 @default.
- W2938674411 creator A5013758739 @default.
- W2938674411 creator A5014723221 @default.
- W2938674411 creator A5022635768 @default.
- W2938674411 creator A5024206518 @default.
- W2938674411 creator A5027110312 @default.
- W2938674411 creator A5033490277 @default.
- W2938674411 creator A5038480839 @default.
- W2938674411 creator A5040983243 @default.
- W2938674411 creator A5041151640 @default.
- W2938674411 creator A5041232625 @default.
- W2938674411 creator A5058159511 @default.
- W2938674411 creator A5058649874 @default.
- W2938674411 creator A5061137450 @default.
- W2938674411 creator A5078158622 @default.
- W2938674411 creator A5080234581 @default.
- W2938674411 creator A5082857859 @default.
- W2938674411 creator A5086682354 @default.
- W2938674411 creator A5088969268 @default.
- W2938674411 creator A5089784531 @default.
- W2938674411 date "2019-07-01" @default.
- W2938674411 modified "2023-10-14" @default.
- W2938674411 title "KIAA1199 promotes sorafenib tolerance and the metastasis of hepatocellular carcinoma by activating the EGF/EGFR-dependent epithelial-mesenchymal transition program" @default.
- W2938674411 cites W1584234966 @default.
- W2938674411 cites W1594203091 @default.
- W2938674411 cites W1964081206 @default.
- W2938674411 cites W1984250533 @default.
- W2938674411 cites W1985569200 @default.
- W2938674411 cites W1989262480 @default.
- W2938674411 cites W1994193851 @default.
- W2938674411 cites W1996462110 @default.
- W2938674411 cites W2009741112 @default.
- W2938674411 cites W2017592190 @default.
- W2938674411 cites W2018038784 @default.
- W2938674411 cites W2019218097 @default.
- W2938674411 cites W2058390096 @default.
- W2938674411 cites W2070396671 @default.
- W2938674411 cites W2075500360 @default.
- W2938674411 cites W2080337585 @default.
- W2938674411 cites W2107441200 @default.
- W2938674411 cites W2116859091 @default.
- W2938674411 cites W2144522854 @default.
- W2938674411 cites W2157923000 @default.
- W2938674411 cites W2165200432 @default.
- W2938674411 cites W2240829153 @default.
- W2938674411 cites W2594785299 @default.
- W2938674411 cites W2606001457 @default.
- W2938674411 cites W2767110894 @default.
- W2938674411 cites W2787520936 @default.
- W2938674411 cites W2792902849 @default.
- W2938674411 cites W2794045676 @default.
- W2938674411 cites W2883204623 @default.
- W2938674411 cites W2890251081 @default.
- W2938674411 cites W2900809514 @default.
- W2938674411 cites W2917837889 @default.
- W2938674411 cites W811338841 @default.
- W2938674411 doi "https://doi.org/10.1016/j.canlet.2019.03.049" @default.
- W2938674411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30980868" @default.
- W2938674411 hasPublicationYear "2019" @default.
- W2938674411 type Work @default.
- W2938674411 sameAs 2938674411 @default.
- W2938674411 citedByCount "38" @default.
- W2938674411 countsByYear W29386744112019 @default.
- W2938674411 countsByYear W29386744112020 @default.
- W2938674411 countsByYear W29386744112021 @default.
- W2938674411 countsByYear W29386744112022 @default.
- W2938674411 countsByYear W29386744112023 @default.
- W2938674411 crossrefType "journal-article" @default.
- W2938674411 hasAuthorship W2938674411A5005549879 @default.
- W2938674411 hasAuthorship W2938674411A5013758739 @default.
- W2938674411 hasAuthorship W2938674411A5014723221 @default.
- W2938674411 hasAuthorship W2938674411A5022635768 @default.
- W2938674411 hasAuthorship W2938674411A5024206518 @default.
- W2938674411 hasAuthorship W2938674411A5027110312 @default.
- W2938674411 hasAuthorship W2938674411A5033490277 @default.
- W2938674411 hasAuthorship W2938674411A5038480839 @default.
- W2938674411 hasAuthorship W2938674411A5040983243 @default.
- W2938674411 hasAuthorship W2938674411A5041151640 @default.
- W2938674411 hasAuthorship W2938674411A5041232625 @default.
- W2938674411 hasAuthorship W2938674411A5058159511 @default.
- W2938674411 hasAuthorship W2938674411A5058649874 @default.
- W2938674411 hasAuthorship W2938674411A5061137450 @default.
- W2938674411 hasAuthorship W2938674411A5078158622 @default.
- W2938674411 hasAuthorship W2938674411A5080234581 @default.
- W2938674411 hasAuthorship W2938674411A5082857859 @default.
- W2938674411 hasAuthorship W2938674411A5086682354 @default.
- W2938674411 hasAuthorship W2938674411A5088969268 @default.
- W2938674411 hasAuthorship W2938674411A5089784531 @default.
- W2938674411 hasConcept C121608353 @default.
- W2938674411 hasConcept C126322002 @default.
- W2938674411 hasConcept C143998085 @default.
- W2938674411 hasConcept C1491633281 @default.
- W2938674411 hasConcept C2778019345 @default.
- W2938674411 hasConcept C2778695046 @default.
- W2938674411 hasConcept C2779013556 @default.
- W2938674411 hasConcept C502942594 @default.